Blistex requests lip care category exemption from FDA's proposed OTC labeling reg.
This article was originally published in The Rose Sheet
Executive Summary
OTC LABEL REG EXEMPTION FOR LIP PRODUCTS SOUGHT BY BLISTEX because "these products, whether sold in cartons or sold uncartoned...are too small to comply with the formatting requirements," the lip care company maintains in Oct. 6 comments on FDA's proposed over-the-counter drug label reform initiative. Therefore, Blistex requests that "the agency provide...a regulation exempting lip care products." Prepared by the Washington, D.C.-based law firm Hyman, Phelps & McNamara, Blistex' comments petition for a specific product category exemption that would include medicated lip balms in pot and stick form and lipsticks with sunscreens.